Thrivent Financial for Lutherans lowered its position in Owens & Minor, Inc. (NYSE:OMI – Get Rating) by 0.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 78,197 shares of the company’s stock after selling 622 shares during the period. Thrivent Financial for Lutherans’ holdings in Owens & Minor were worth $1,527,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Advisor Group Holdings Inc. boosted its stake in Owens & Minor by 10.1% in the first quarter. Advisor Group Holdings Inc. now owns 4,858 shares of the company’s stock worth $214,000 after buying an additional 444 shares in the last quarter. US Bancorp DE boosted its stake in shares of Owens & Minor by 67.4% during the first quarter. US Bancorp DE now owns 1,145 shares of the company’s stock valued at $51,000 after purchasing an additional 461 shares during the period. Delphia USA Inc. boosted its stake in shares of Owens & Minor by 8.2% during the first quarter. Delphia USA Inc. now owns 6,163 shares of the company’s stock valued at $271,000 after purchasing an additional 469 shares during the period. Baird Financial Group Inc. boosted its stake in shares of Owens & Minor by 3.5% during the first quarter. Baird Financial Group Inc. now owns 14,784 shares of the company’s stock valued at $650,000 after purchasing an additional 503 shares during the period. Finally, SummerHaven Investment Management LLC boosted its stake in shares of Owens & Minor by 2.3% during the fourth quarter. SummerHaven Investment Management LLC now owns 24,991 shares of the company’s stock valued at $488,000 after purchasing an additional 573 shares during the period.
Owens & Minor Price Performance
Shares of Owens & Minor stock opened at $20.28 on Friday. The company has a quick ratio of 0.60, a current ratio of 1.39 and a debt-to-equity ratio of 2.56. The company has a market cap of $1.55 billion, a PE ratio of -36.21, a P/E/G ratio of 3.97 and a beta of 0.57. The business has a 50 day moving average of $15.20 and a 200 day moving average of $18.11. Owens & Minor, Inc. has a 52 week low of $11.79 and a 52 week high of $37.03.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the company. UBS Group increased their price objective on Owens & Minor from $22.00 to $24.00 in a research note on Monday, May 8th. Robert W. Baird increased their price objective on Owens & Minor from $18.00 to $21.00 in a research note on Monday, May 8th. Citigroup dropped their price objective on Owens & Minor from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, March 8th. Credit Suisse Group dropped their price objective on Owens & Minor from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Tuesday, March 7th. Finally, StockNews.com started coverage on Owens & Minor in a report on Thursday. They set a “hold” rating for the company. Two research analysts have rated the stock with a sell rating and four have issued a hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $18.83.
Insiders Place Their Bets
In other Owens & Minor news, SVP Jonathan A. Leon sold 6,000 shares of the stock in a transaction on Wednesday, March 22nd. The stock was sold at an average price of $13.50, for a total value of $81,000.00. Following the completion of the transaction, the senior vice president now owns 106,723 shares in the company, valued at $1,440,760.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 3.59% of the stock is owned by corporate insiders.
Owens & Minor Profile
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations.
- Get a free copy of the StockNews.com research report on Owens & Minor (OMI)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Get Rating).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.